Ferric Carboxymaltose

羧基麦芽糖铁

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameFerric Carboxymaltose
Drug Alias Name羧基芽糖铁ferricum carboxymaltosumcarboxymaltose ferriqueFerinjectInjectafer +[8] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIron deficiencyIntraoperative ComplicationsGraft vs Host Disease +[25] 
Global Approved IndicationsIron deficiencyAnemia, Iron-Deficiency
Approved Indications in ChinaAnemia, Iron-Deficiency
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2007/07/19
Country/TerritoryCzechiaBelgiumBulgaria +[35] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesZeria PharmaceuticalUniversity Medical Center GroningenUniversity Of Lagos +[10] 
Inactive CompaniesSandozGwt-Tud GmbhMedical University Of Graz +[15] 
Active IndicationsIron deficiencyIntraoperative ComplicationsGraft vs Host Disease +[8] 
Inactive IndicationsDiabetes Mellitus, Type 2ThrombocytosisMyocardial Infarction +[17] 

Other Information

ATC CodeB03A
Related LinksWikipediaDrugBankKEGG